NEW YORK–(BUSINESS WIRE)–DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price […]

BERKELEY, Calif.–(BUSINESS WIRE)–$CRBU–Caribou Biosciences, Inc., (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the closing of its previously announced initial public offering of 19,000,000 shares of common […]

CHICAGO–(BUSINESS WIRE)–Ryan Specialty Group Holdings, Inc. (“Ryan Specialty”) today announced that the underwriters of the previously announced initial public offering of 56,918,278 shares of its Class A common stock exercised […]

NEW YORK–(BUSINESS WIRE)–ROX Financial LP today announced the launch of its initial public offering of 8,250,000 Series A shares, which represent limited partner interests associated with a series of ROX […]

SALT LAKE CITY–(BUSINESS WIRE)–The Better Being Co. (“Better Being” or “the Company”) today announced that it has launched the roadshow for its proposed initial public offering. Better Being is a […]

AUSTIN, Texas–(BUSINESS WIRE)–#AI–CS Disco, Inc. (“DISCO”) today announced the closing of its initial public offering of 7,700,000 shares of its common stock at a price to the public of $32.00 […]

With more than 20 years of meeting, event, and hospitality technology leadership and an established customer base, Cvent has momentum to win substantial market share in the nearly $30 billion […]

LITTLE ROCK, Ark.–(BUSINESS WIRE)–Private investment firm The Stephens Group, LLC (“The Stephens Group”) announced today that its portfolio company DISCO completed its initial public offering. The shares began trading on […]

IRVINE, Calif.–(BUSINESS WIRE)–Xponential Fitness, Inc., a curator of leading boutique fitness brands, today announced the pricing of its initial public offering (“IPO”) of 10,000,000 shares of its Class A common […]

BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the pricing of its upsized initial public offering of 19,000,000 shares of common stock at a […]